prof. dr. Jan De Bleecker
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 12
9000 Gent - Jan.DeBleecker@UGent.be
Show
Sort by
-
- Journal Article
- open access
Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial.
-
- Journal Article
- open access
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT.
-
- Journal Article
- open access
Diagnostic muscle biopsies in the era of genetics: the added value of myopathology in a selection of limb-girdle muscular dystrophy patients.
-
- Journal Article
- open access
Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer's disease.
-
- Journal Article
- open access
Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial.
-
- Journal Article
- open access
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.
-
- Journal Article
- A1
- open access
No association of CpG SNP rs9357140 with onset age in Belgian C9orf72 repeat expansion carriers
-
Myotonic dystrophy type 1 as a major risk factor for severe COVID-19?
-
- Journal Article
- open access
The myokine GDF-15 is a potential biomarker for myositis and associates with the protein aggregates of sporadic inclusion body myositis.
-
- Journal Article
- open access
Multisystem proteinopathy due to a homozygous p.Arg159His <i>VCP</i> mutation: A tale of the unexpected.